DRIODarioHealth Corp.vs its industry peers
A metric-by-metric comparison of DarioHealth Corp. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DRIOEsta | $65M#5 | 1.2x#1 | 1.2x#1 | 2.9x#3 | -17.3%#3 | 2.4%#3 | -163.9%#3 | -75.7%#2 | -41.6%#2 | 3#2 | 5.9%#2 | — |
| MBOT | $98M#1 | — | 1.4x#2 | 836.1x#4 | -88.5%#4 | -14.8%#4 | -12613.0%#4 | -19.1%#1 | -22.4%#1 | 5#1 | -56.4%#5 | — |
| GUTS | $91M#2 | — | — | — | -100.0%#5 | -105.2%#5 | — | — | — | — | -42.6%#3 | — |
| LUNG | $84M#3 | — | 2.1x#3 | 0.9x#1 | 8.0%#2 | 4.2%#2 | -59.3%#1 | -137.8%#3 | -257.0%#3 | 3#2 | 24.1%#1 | — |
| CVRX | $81M#4 | — | 4.0x#4 | 1.4x#2 | 10.4%#1 | 11.1%#1 | -90.5%#2 | -267.2%#4 | -296.8%#4 | 3#2 | -56.3%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice